Zolendronic Acid Zuvius

Zoledronic acid, sold under the brand name Zuvius, is a medication used to treat and prevent osteoporosis in postmenopausal women and men. It belongs to a class of drugs known as bisphosphonates, which help to increase bone density and reduce the risk of fractures.

Indication:

Zoledronic acid Zuvius is indicated for the treatment of osteoporosis in postmenopausal women and men at increased risk of fractures. It is also used to prevent skeletal-related events in patients with bone metastases from solid tumors.

Dosage:

The recommended dosage of Zoledronic acid Zuvius for the treatment of osteoporosis is a single 5 mg infusion once a year. For the prevention of skeletal-related events in patients with bone metastases, the recommended dosage is a single 4 mg infusion every 3 to 4 weeks.

It is important to follow the dosing schedule prescribed by your healthcare provider and to receive the medication under the supervision of a healthcare professional, as Zoledronic acid is typically administered intravenously.

As with any medication, it is important to discuss with your healthcare provider about the indication and dosage of Zoledronic acid Zuvius to ensure it is appropriate for your specific condition and medical history.